Dynamics in Post-pandemic Global Parkinsons disease Drug Industry: Supply and Demand, Markets and Prices 2021-2027
Report Code: KNJ668321
Publisher: Date of Publish:
No. of Pages: 163 Category: Pharmaceuticals and Healthcare Publisher: Date of Publish:
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Parkinsons disease Drug market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Parkinsons disease Drug market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category Carbidopa/Levodopa Dopamine Receptor Agonists MAO-Inhibitors Segmented by End User/Segment Hospital Online Retail Pharmacies Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Wockhardt UCB Teva Sun Pharma Novartis AG Merck Lundbeck Impax Laboratories GSK Boehringer Ingelheim Bausch Health Acadia AbbVie
Table of Contents 1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Parkinsons disease Drug Market Status and Forecast (2016-2027) 1.3.2 Global Parkinsons disease Drug Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis 2 Global Parkinsons disease Drug Supply by Company 2.1 Global Parkinsons disease Drug Sales Volume by Company 2.2 Global Parkinsons disease Drug Sales Value by Company 2.3 Global Parkinsons disease Drug Price by Company 2.4 Parkinsons disease Drug Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate 3 Global and Regional Parkinsons disease Drug Market Status by Category 3.1 Parkinsons disease Drug Category Introduction 3.1.1 Carbidopa/Levodopa 3.1.2 Dopamine Receptor Agonists 3.1.3 MAO-Inhibitors 3.2 Global Parkinsons disease Drug Market by Category 3.2.1 Global Parkinsons disease Drug Sales Volume by Category (2016-2021) 3.2.2 Global Parkinsons disease Drug Sales Value by Category (2016-2021) 3.2.3 Global Parkinsons disease Drug Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category 4 Global and Regional Parkinsons disease Drug Market Status by End User/Segment 4.1 Parkinsons disease Drug Segment by End User/Segment 4.1.1 Hospital 4.1.2 Online 4.1.3 Retail Pharmacies 4.2 Global Parkinsons disease Drug Market by End User/Segment 4.2.1 Global Parkinsons disease Drug Sales Volume by End User/Segment (2016-2021) 4.2.2 Global Parkinsons disease Drug Sales Value by End User/Segment (2016-2021) 4.2.3 Global Parkinsons disease Drug Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment 5 Global Parkinsons disease Drug Market Status by Region 5.1 Global Parkinsons disease Drug Market by Region 5.1.1 Global Parkinsons disease Drug Sales Volume by Region 5.1.2 Global Parkinsons disease Drug Sales Value by Region 5.2 North America Parkinsons disease Drug Market Status 5.3 Europe Parkinsons disease Drug Market Status 5.4 Asia Pacific Parkinsons disease Drug Market Status 5.5 Central & South America Parkinsons disease Drug Market Status 5.6 Middle East & Africa Parkinsons disease Drug Market Status 6 North America Parkinsons disease Drug Market Status 6.1 North America Parkinsons disease Drug Market by Country 6.1.1 North America Parkinsons disease Drug Sales Volume by Country (2016-2021) 6.1.2 North America Parkinsons disease Drug Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico 7 Europe Parkinsons disease Drug Market Status 7.1 Europe Parkinsons disease Drug Market by Country 7.1.1 Europe Parkinsons disease Drug Sales Volume by Country (2016-2021) 7.1.2 Europe Parkinsons disease Drug Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain 8 Asia Pacific Parkinsons disease Drug Market Status 8.1 Asia Pacific Parkinsons disease Drug Market by Country 8.1.1 Asia Pacific Parkinsons disease Drug Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Parkinsons disease Drug Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia 9 Central & South America Parkinsons disease Drug Market Status 9.1 Central & South America Parkinsons disease Drug Market by Country 9.1.1 Central & South America Parkinsons disease Drug Sales Volume by Country (2016-2021) 9.1.2 Central & South America Parkinsons disease Drug Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia 10 Middle East & Africa Parkinsons disease Drug Market Status 10.1 Middle East & Africa Parkinsons disease Drug Market by Country 10.1.1 Middle East & Africa Parkinsons disease Drug Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Parkinsons disease Drug Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia 11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Parkinsons disease Drug Manufacturing Cost Analysis 11.5 Parkinsons disease Drug Sales Channel and Distributors Analysis 11.5.1 Parkinsons disease Drug Sales Channel 11.5.2 Parkinsons disease Drug Distributors 11.6 Parkinsons disease Drug Downstream Major Buyers 12 Global Parkinsons disease Drug Market Forecast by Category and by End User/Segment 12.1 Global Parkinsons disease Drug Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Parkinsons disease Drug Forecast by Category 12.2.1 Global Parkinsons disease Drug Sales Volume Forecast by Category 12.2.2 Global Parkinsons disease Drug Sales Value Forecast by Category 12.2.3 Global Parkinsons disease Drug Price Forecast by Category 12.3 Global Parkinsons disease Drug Forecast by End User/Segment 12.3.1 Global Parkinsons disease Drug Sales Volume Forecast by End User/Segment 12.3.2 Global Parkinsons disease Drug Sales Value Forecast by End User/Segment 12.3.3 Global Parkinsons disease Drug Price Forecast by End User/Segment 13 Global Parkinsons disease Drug Market Forecast by Region/Country 13.1 Global Parkinsons disease Drug Market Forecast by Region (2022-2027) 13.1.1 Global Parkinsons disease Drug Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Parkinsons disease Drug Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast 14 Key Participants Company Information 14.1 Wockhardt 14.1.1 Company Information 14.1.2 Parkinsons disease Drug Product Introduction 14.1.3 Wockhardt Parkinsons disease Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 UCB 14.2.1 Company Information 14.2.2 Parkinsons disease Drug Product Introduction 14.2.3 UCB Parkinsons disease Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Teva 14.3.1 Company Information 14.3.2 Parkinsons disease Drug Product Introduction 14.3.3 Teva Parkinsons disease Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Sun Pharma 14.4.1 Company Information 14.4.2 Parkinsons disease Drug Product Introduction 14.4.3 Sun Pharma Parkinsons disease Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Novartis AG 14.5.1 Company Information 14.5.2 Parkinsons disease Drug Product Introduction 14.5.3 Novartis AG Parkinsons disease Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 Merck 14.6.1 Company Information 14.6.2 Parkinsons disease Drug Product Introduction 14.6.3 Merck Parkinsons disease Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 Lundbeck 14.7.1 Company Information 14.7.2 Parkinsons disease Drug Product Introduction 14.7.3 Lundbeck Parkinsons disease Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis 14.8 Impax Laboratories 14.8.1 Company Information 14.8.2 Parkinsons disease Drug Product Introduction 14.8.3 Impax Laboratories Parkinsons disease Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.8.4 SWOT Analysis 14.9 GSK 14.9.1 Company Information 14.9.2 Parkinsons disease Drug Product Introduction 14.9.3 GSK Parkinsons disease Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.9.4 SWOT Analysis 14.10 Boehringer Ingelheim 14.10.1 Company Information 14.10.2 Parkinsons disease Drug Product Introduction 14.10.3 Boehringer Ingelheim Parkinsons disease Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.10.4 SWOT Analysis 14.11 Bausch Health 14.12 Acadia 14.13 AbbVie 15 Conclusion 16 Methodology
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com